Pharmacist Information
Zydus Pharmaceuticals (USA) Inc. appreciates your
interest in our product and we have included this
information to assist you in managing your patient’s
anticoagulation therapy.
Warfarin Tablet identification
Chart
 This tablet identification chart is a helpful
comparison chart which shows Zydus Warfarin Sodium
Tablets, USP have similar colored tablets to what
Coumadin and other generic warfarin sodium tablets in
all 9 strengths.
 Download
Zydus Product Specifications
chart
For a detailed list of NDC numbers, bottle count
sizes and shipping information of all 9 strengths of
Zydus Warfarin Sodium Tablets’ USP.
NDC # Product Description Potency Size Case Pack Case
Weight (Lbs) Case Dimension (LWH - Inch) Case Cube
| NDC# |
Product
Description |
Potency |
Size |
Case
Pack |
Case
Weight
(Lbs) |
Case
Dimentions
(LWH - Inch) |
Case
Cube |
| 68382-052-01 |
Warfarin Sodium Tablets |
1 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-052-10 |
Warfarin Sodium Tablets |
1 mg |
1000 |
12 |
7.71 |
12.48 x 9.41 x 6.10 |
0.41 |
| 68382-053-01 |
Warfarin Sodium Tablets |
2 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-053-10 |
Warfarin Sodium Tablets |
2 mg |
1000 |
12 |
7.71 |
12.48 x 9.41 x 6.10 |
0.41 |
| 68382-064-01 |
Warfarin Sodium Tablets |
2.5 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-064-10 |
Warfarin Sodium Tablets |
2.5 mg |
1000 |
12 |
7.71 |
12.48 x 9.41 x 6.10 |
0.41 |
| 68382-054-01 |
Warfarin Sodium Tablets |
3 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-054-10 |
Warfarin Sodium Tablets |
3 mg |
1000 |
12 |
7.71 |
12.48 x 9.41 x 6.10 |
0.41 |
| 68382-055-01 |
Warfarin Sodium Tablets |
4 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-055-10 |
Warfarin Sodium Tablets |
4 mg |
1000 |
12 |
7.71 |
12.48 x 9.41 x 6.10 |
0.41 |
| 68382-056-01 |
Warfarin Sodium Tablets |
5 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-056-10 |
Warfarin Sodium Tablets |
5 mg |
1000 |
12 |
7.71 |
12.48 x 9.41 x 6.10 |
0.41 |
| 68382-057-01 |
Warfarin Sodium Tablets |
6 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-058-01 |
Warfarin Sodium Tablets |
7.5 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
| 68382-059-01 |
Warfarin Sodium Tablets |
10 mg |
100 |
24 |
3.25 |
11.54 x 7.76 x 4.06 |
0.21 |
Bioequivalence Chart
Results of Zydus bioequivalencey study.
 Continuing Education Program
Title: Understanding Warfarin
Goal: To enable pharmacists to provide
evidence-based counseling to patients using warfarin.
Learning Objectives: Upon completion of the program,
participants should be able to:
- Describe the FDA’s process for determining
bioequivalence of narrow therapeutic index drugs
- Describe health practitioners’ perspectives on
the use of generic warfarin
- Describe results of recently published evidence
based studies regarding the use of warfarin
- Relate the results of recently published
evidence based studies regarding the use of warfarin
to other health care practitioners
- Provide evidence-based counseling to patients.
LINK to Continuing Education Program
|
